{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:43:17Z","timestamp":1793194997939,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"\n Importance<\/jats:title>\n Although dopamine is implicated in the pathophysiology of bipolar disorder (BD), the precise alterations in the dopaminergic system remain unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess dopamine transporter (DAT) density in the striatum in patients with BD with current and recently remitted mania in comparison to healthy control individuals and its correlation with severity of manic symptoms.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n This cross-sectional study conducted in a tertiary care referral center for mood disorders in Vancouver, British Columbia, Canada, recruited 26 patients with BD (9 with current mania; 17 with recently remitted mania) and 21 matched healthy control individuals. DAT density was measured using positron emission tomography with [\n 11<\/jats:sup>\n C]d-threo-methylphenidate (MP). The differences between the groups in nondisplaceable binding potential (BPND) for DAT was assessed using statistical parametric mapping. The study was conducted from November 2001 to February 2007 and the data were analyzed from November 2020 to December 2021.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n DAT density as indexed by BPND for MP across groups; manic symptom severity as measured with the Young Mania Rating Scale (YMRS) and correlated with BPND values in patients with BD.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 47 total participants (mean [SD] age, 37.8 [14.4] years), 27 (57.4%) were female; 26 individuals had BD (9 with current mania and 17 with recently remitted mania) and there were 21 healthy control individuals. MP BPND was significantly lower in patients with BD in the right putamen and nucleus accumbens (mean reduction [MR]\u2009=\u200922%; cluster level familywise error [FWE]\u2013corrected\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) as well as left putamen and caudate (MR\u2009=\u200924%; cluster level FWE\u2013corrected\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). The reduction in BPND was more extensive and pronounced in patients with current mania, while patients with recently remitted mania had lower BPND in the left striatum but not the right. There was a significant negative correlation between YMRS scores and MP BPND in the right striatum in patients with current mania (\u03c1\u2009=\u2009\u22120.93; 95% CI, \u22120.99 to \u22120.69;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and those with recently remitted mania (\u03c1\u2009=\u20090.64; 95% CI, \u22120.86 to \u22120.23;\n P<\/jats:italic>\n \u2009=\u2009.005) but not in the left striatum in either group.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n These findings indicate that mania was associated with reduced DAT density and remitted mania was associated with DAT levels that approximated those present in individuals without BD. These results have potential implications for drug development for mania.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2022.3541","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T11:00:46Z","timestamp":1667386846000},"page":"1217","source":"Crossref","is-referenced-by-count":28,"title":["A Positron Emission Tomography Study of Dopamine Transporter Density in Patients With Bipolar Disorder With Current Mania and Those With Recently Remitted Mania"],"prefix":"10.1001","volume":"79","author":[{"given":"Lakshmi N.","family":"Yatham","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Liddle","sequence":"additional","affiliation":[{"name":"Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Interior Health Authority, Kelowna, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Saraf","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Vafai","sequence":"additional","affiliation":[{"name":"Positron Emission Tomography and Magnetic Resonance Imaging, David Mowafaghian Centre for Brain Health, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Sossi","sequence":"additional","affiliation":[{"name":"Positron Emission Tomography and Magnetic Resonance Imaging, David Mowafaghian Centre for Brain Health, Vancouver, British Columbia, Canada"},{"name":"Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"yoi220072r1","first-page":"472","article-title":"L-dopa, behavioral activation and psychopathology.","volume":"50","author":"Murphy","year":"1972","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"issue":"10","key":"yoi220072r2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1176\/ajp.133.10.1177","article-title":"A dopaminergic mechanism in mania.","volume":"133","author":"Gerner","year":"1976","journal-title":"Am J Psychiatry"},{"issue":"5","key":"yoi220072r3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/archpsyc.1974.01760170049008","article-title":"Inhibition of dopamine-b-hydroxylase in manic patients. a clinical trial and fusaric acid.","volume":"31","author":"Sack","year":"1974","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"yoi220072r4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/cpt.1971.12.issue-2part1","article-title":"Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.","volume":"12","author":"Brodie","year":"1971","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"yoi220072r5","first-page":"3","article-title":"Recent advances in treatment of acute mania.","volume":"11","author":"Chou","year":"1991","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"yoi220072r6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/S0033291714001305","article-title":"A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania.","volume":"45","author":"Yildiz","year":"2015","journal-title":"Psychol Med"},{"issue":"6","key":"yoi220072r7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archpsyc.1995.03950180057008","article-title":"In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.","volume":"52","author":"Pearlson","year":"1995","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi220072r8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","article-title":"A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia.","volume":"74","author":"Jauhar","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"yoi220072r9","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1176\/appi.ajp.159.10.1718","article-title":"PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania.","volume":"159","author":"Yatham","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"5","key":"yoi220072r10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1176\/appi.ajp.159.5.768","article-title":"PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.","volume":"159","author":"Yatham","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"9","key":"yoi220072r11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states.","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"suppl 1","key":"yoi220072r12","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1055\/s-0030-1248300","article-title":"Dopamine release in the prefrontal cortex and striatum: Temporal and behavioural aspects.","volume":"43","author":"Hauber","year":"2010","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"yoi220072r13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0893-133X(95)00150-C","article-title":"Dopamine receptor mRNA expression in human striatum and neocortex.","volume":"15","author":"Meador-Woodruff","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"yoi220072r14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol"},{"issue":"12","key":"yoi220072r15","first-page":"2162","article-title":"A new PET ligand for the dopamine transporter: studies in the human brain.","volume":"36","author":"Volkow","year":"1995","journal-title":"J Nucl Med"},{"issue":"5","key":"yoi220072r16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(ISSN)1099-1344","article-title":"An improved method for the radiosynthesis of [11C]d-threo- methylphenidate.","volume":"49","author":"Studenov","year":"2006","journal-title":"J Labelled Comp Radiopharm"},{"issue":"9","key":"yoi220072r17","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands.","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"yoi220072r18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nimg.1997.0303","article-title":"Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.","volume":"6","author":"Gunn","year":"1997","journal-title":"Neuroimage"},{"issue":"2","key":"yoi220072r19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/syn.v64:2","article-title":"Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.","volume":"64","author":"Troiano","year":"2010","journal-title":"Synapse"},{"issue":"2","key":"yoi220072r20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00259-012-2276-8","article-title":"European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.","volume":"40","author":"Varrone","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"yoi220072r21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0014-2999(95)00233-B","article-title":"Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.","volume":"281","author":"Gatley","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"yoi220072r22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-2952(97)00192-5","article-title":"Effects of a chronic lithium treatment on central dopamine neurotransporters.","volume":"54","author":"Carli","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"yoi220072r23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0028-3908(81)90182-9","article-title":"Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawal.","volume":"20","author":"Ahluwalia","year":"1981","journal-title":"Neuropharmacology"},{"issue":"7","key":"yoi220072r24","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/ejn.2008.25.issue-7","article-title":"Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.","volume":"25","author":"Wang","year":"2007","journal-title":"Eur J Neurosci"},{"key":"yoi220072r25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuropharm.2017.07.020","article-title":"Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.","volume":"125","author":"Green","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"yoi220072r26","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.1","article-title":"Changes in striatal dopamine transporters in bipolar disorder and valproate treatment.","volume":"64","author":"Hsueh","year":"2021","journal-title":"Eur Psychiatry"},{"issue":"1","key":"yoi220072r27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bdi.2010.12.issue-1","article-title":"Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.","volume":"12","author":"Chang","year":"2010","journal-title":"Bipolar Disord"},{"issue":"3-4","key":"yoi220072r28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000106476","article-title":"A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.","volume":"55","author":"Amsterdam","year":"2007","journal-title":"Neuropsychobiology"},{"issue":"2-3","key":"yoi220072r29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jad.2012.03.007","article-title":"Greater striatal dopamine transporter density may be associated with major depressive episode.","volume":"141","author":"Amsterdam","year":"2012","journal-title":"J Affect Disord"},{"issue":"4","key":"yoi220072r30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/bdi.2011.13.issue-4","article-title":"Striatal dopamine transporter availability in unmedicated bipolar disorder.","volume":"13","author":"Anand","year":"2011","journal-title":"Bipolar Disord"},{"key":"yoi220072r31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuroscience.2015.08.041","article-title":"Animal models of bipolar mania: The past, present and future.","volume":"321","author":"Logan","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"yoi220072r32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/schbul\/sbr111","article-title":"Striatal presynaptic dopamine in schizophrenia, part I: meta-analysis of dopamine active transporter (DAT) density.","volume":"39","author":"Fusar-Poli","year":"2013","journal-title":"Schizophr Bull"},{"issue":"6","key":"yoi220072r33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/01.rlu.0000262980.98342.dd","article-title":"Dopamine transporter binding in smokers and nonsmokers.","volume":"32","author":"Newberg","year":"2007","journal-title":"Clin Nucl Med"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2798230\/jamapsychiatry_yatham_2022_oi_220072_1669908221.38494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:02:20Z","timestamp":1670410940000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2798230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.3541","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}